The Effect of Power-walking in Phase 2 Cardiac Rehabilitation Program
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective To evaluate the eff ects of power walking (PW) training on a treadmill in patients with coronary heart disease (CHD) and to compare the cardiovascular eff ects of PW with usual walking (UW). Method Patients were recruited as participants in phase 2 cardiac rehabilitation program after receiving percutaneous coronary intervention (PCI) due to acute coronary syndrome from our hospital. Th e participants were divided into the PW group (n=16) and UW group (n=18). All participants received graded exercise test (GXT)and signifi cant diff erence in maximal oxygen consumption (VO2Max) was not observed between the groups. Aerobic exercise training on treadmill was given for 50 minutes per session, three times a week, for six weeks. Physiological and hematological parameters were tested before and 6 weeks after the cardiac rehabilitation program. Exercise duration, VO2Max, heart rate, blood pressure, and rate pressure product were evaluated through graded exercise test. Hematological measurements included serum lipid profi le, and high-sensitivity C reactive protein (hs-CRP). Results Th ere were no signifi cant diff erences in resting heart rate, maximal heart rate, resting systolic and diastolic blood pressures, lipid profi le, hs-CRP, VO2Max, and RPP between the PW group and UW group. However, after 6weeks of the intervention, VO2Max in the PW group (36.03±5.69 ml/kg/min) was signifi cantly higher than that in the UW group (29.73±5.63 ml/kg/min) (p<0.05). Conclusion After six weeks of phase 2 cardiac rehabilitation program, the PW group showed significant improvement in VO2Max than the UW group. Thus, it will beneficial to recommend power walking in cardiac rehabilitation program.
Abstract
Objective To evaluate the eff ects of power walking (PW) training on a treadmill in patients with coronary heart disease (CHD) and to compare the cardiovascular eff ects of PW with usual walking (UW). Method Patients were recruited as participants in phase 2 cardiac rehabilitation program after receiving percutaneous coronary intervention (PCI) due to acute coronary syndrome from our hospital. Th e participants were divided into the PW group (n=16) and UW group (n=18). All participants received graded exercise test (GXT)and signifi cant diff erence in maximal oxygen consumption (VO2Max) was not observed between the groups. Aerobic exercise training on treadmill was given for 50 minutes per session, three times a week, for six weeks. Physiological and hematological parameters were tested before and 6 weeks after the cardiac rehabilitation program. Exercise duration, VO2Max, heart rate, blood pressure, and rate pressure product were evaluated through graded exercise test. Hematological measurements included serum lipid profi le, and high-sensitivity C reactive protein (hs-CRP). Results Th ere were no signifi cant diff erences in resting heart rate, maximal heart rate, resting systolic and diastolic blood pressures, lipid profi le, hs-CRP, VO2Max, and RPP between the PW group and UW group. However, after 6weeks of the intervention, VO2Max in the PW group (36.03±5.69 ml/kg/min) was signifi cantly higher than that in the UW group (29.73±5.63 ml/kg/min) (p<0.05). Conclusion After six weeks of phase 2 cardiac rehabilitation program, the PW group showed significant improvement in VO2Max than the UW group. Thus, it will beneficial to recommend power walking in cardiac rehabilitation program.
참고문헌 (29)
- Thompson PD, "Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism", Circulation, 107, pp.3109~3116 (2003), Subcommittee on Physical Activity
- Kelley GA, "Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials", Prev Med, 38, pp.651~661 (2004)
- Kelley GA, "Walking and resting blood pressure in adults: a meta-analysis", Prev Med, 33, pp.120~127 (2001)
- Franklin BA, "Walking: the undervalued prescription", Prev Cardiol, 9, pp.56~59 (2006)
- Quell KJ, "Is brisk walking an adequate aerobic training stimulus for cardiac patients?", Chest, 122, pp.1852~1856 (2002)
- Tully MA, "Brisk walking, fitness and cardiovascular risk: a randomized controlled trial in primary care", Prev Med, 41, pp.622~628 (2005)
- Aamot IL, "Onset of exercise training 14 days after uncomplicated myocardial infarction: a randomized controlled trial", Eur J Cardiovasc Prev Rehabil, 17, pp.387~392 (2010)
- Morris JN, "Walking to health", Sports Med, 23, pp.306~332 (1999)
- Hardman AE, "Brisk walking improves endurance fi tness without changing body fatness in previously sedentary women", Eur J Appl Physiol Occup Physiol, 65, pp.354~359 (1992)
- Greiwe JS, "Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training", J Appl Physiol, 86, pp.531~535 (1999)
- Martin PE, "Eff ects of age and physical activity status on the speed-aerobic demand relationship of walking", J Appl Physiol, 73, pp.200~206 (1992)
- 박동식, "파워 보행과 달리기의 운동 강도 비교", 대한스포츠의학회지, 26(2), pp.175~179 (2008), 대한스포츠의학회
- Butts NK, "Energy costs of walking on a dual-action treadmill in men and women", Med Sci Sports Exerc, 27, pp.121~125 (1995)
- Gibbons RJ, "ACC", AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology, J Am Coll Cardiol, pp.2002, 40[DOI]
- Karvonen MJ, "The effects of training on heart rate; a longitudinal study", Ann Med Exp Biol Fenn, 35, pp.307~315 (1957)
- Scheur J, "Cardiovascular adaptations to physical training", Annu Rev Physiol, 39, pp.221~251 (1997)
- Holloszy JO, "Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle", J Bio Chem, 242, pp.2278~2282 (1967)
- Kraus WE, "Effects of the amount and intensity of exercise on plasma lipoproteins", N Eng J Med, 347, pp.1483~1492 (2002)
- Fletcher GF, "Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association", Circulation, 104, pp.1694~1740 (2001)
- 조규권, "파워워킹과 일반보행의 운동학적 및 EMG 비교분석", 한국운동역학회지, 16(2), pp.85~96 (2006), 한국운동역학회
- Laukkanen JA, "The predictive value of cardiorespiratory fi tness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study", Eur Heart J, 25, pp.1428~1437 (2004)
- Myers J, "Exercise capacity and mortality among men referred for exercise testing", N Engl J Med, 346, pp.793~801 (2002)
- Dorn J, "Trevisan M. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction paients: the National Exercise and Heart Disease Project (NEHDP)", Circulation, 100, pp.1764~1769 (1999)
- Sun Y, "Study of exercise and serum lipids in puberty", pp.193~196 (1991), Zhonghua Liu Xing Bing Xue Za Zhi
- Fallon KE, "The acute phase response and exercise: court and fi eld sports", Br J Sports Med, 35, pp.170~173 (2001)
- Mattusch F, "Reduction of the plasma concentration of C-reactive protein following nine months of endurance training", Int J Sports Med, 21, pp.21~24 (2000)
- Smith JK, "Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease", JAMA, 281, pp.1722~1727 (1999)
- Shephard RJ, "Exercise as cardiovascular therapy", Circulation, 99, pp.963~972 (1999)
- 안재기, "허혈성 심장질환 환자에서 심장재활운동 후 운동능력 및 심실기능의 변화", 대한스포츠의학회지, 24(2), pp.229~236 (2006), 대한스포츠의학회